Q: Reuters is reporting that Knight and Eurofarma have teamed up and entered into talks to take a controlling interest in Brazilian pharma company Biotoscana. Might this acquisition be the big one everybody has been waiting for or is it just more tuck-in activity?
People are holding their breath.
People are holding their breath.